Acute Effects of Upper Arm Tissue Flossing on Upper Extremity Performance and Power (AUERTF)
Acute Effects of Upper Arm Tissue Flossing on Closed-Chain Upper Extremity Stability and Explosive Upper-Body Power: A Randomized Sham-Controlled Trial
This randomized sham-controlled trial investigates the acute effects of upper arm tissue flossing on upper extremity performance and power in healthy adults. Tissue flossing is a compression-based intervention that involves wrapping an elastic band around a limb for a short period while performing movement exercises.
Twenty-eight healthy participants are randomly assigned to either an active tissue flossing group or a sham flossing group. The intervention is applied to the dominant upper arm. Upper extremity performance is assessed before the intervention and at 2 and 15 minutes after the intervention using the Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) and the Seated Medicine Ball Throw (SMBT).
The study aims to determine whether a single session of upper arm tissue flossing can produce immediate improvements in upper extremity stability, functional performance, and explosive power compared with a sham intervention
Aperçu de l'étude
Statut
Intervention / Traitement
Description détaillée
Tissue flossing is a relatively new technique used in sports and rehabilitation settings. It involves applying a specialized elastic compression band around a limb while the individual performs active movements. Proposed mechanisms include temporary vascular occlusion followed by reperfusion, alterations in neuromuscular function, and changes in fascial tissue mobility. Although tissue flossing has been investigated for lower extremity performance and range of motion outcomes, evidence regarding its effects on upper extremity performance remains limited.
The purpose of this study is to examine the acute effects of upper arm tissue flossing on upper extremity functional performance and power in healthy adults. This study is designed as a randomized, sham-controlled, parallel-group trial.
A total of 28 healthy volunteers are randomly allocated to either an active tissue flossing group or a sham flossing group. Participants in the active intervention group receive tissue flossing applied to the dominant upper arm using a standardized compression protocol. Participants in the sham group receive a loosely applied band that does not provide therapeutic compression. During band application, participants perform standardized upper extremity movements.
Outcome measurements are obtained at baseline, 2 minutes after intervention, and 15 minutes after intervention. Upper extremity functional performance is assessed using the Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST). Explosive upper-body power is assessed using the Seated Medicine Ball Throw (SMBT).
The primary objective is to determine whether upper arm tissue flossing produces immediate improvements in upper extremity stability and performance compared with a sham intervention. Findings from this study may contribute to understanding the potential role of tissue flossing as a practical strategy for enhancing upper extremity performance in healthy individuals and physically active populations.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Sanliurfa, Turquie (Türkiye)
- Harran University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Age 18-35 years.
- Absence of current upper-extremity pain or dysfunction.
- Ability to safely assume a full push-up position and perform a two-handed seated chest pass.
Exclusion Criteria:
- History of upper-extremity surgery.
- Acute musculoskeletal injury within the preceding 6 months.
- Known vascular disease, coagulation or clotting disorders, uncontrolled hypertension, or any other contraindication to short-term circumferential limb compression.
- Confirmed latex allergy, given that the floss band used in this study was latex-based.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Active Flossing Group
Participants (n=14) receive a structured circumferential compression protocol on their dominant upper arm using an elastic latex floss band stretched to moderate tension, followed by a brief active movement sequence.
|
The floss band is applied to the participant's dominant upper arm by a licensed physiotherapist.
Wrapping proceeds in a distal-to-proximal direction with approximately 50% overlap between layers, terminating just distal to the axilla.
The band is stretched to a standardized elongation between 50% and 70% of its maximal length to generate moderate circumferential compression.
Once wrapped, the participant performs a standardized 2-minute low-to-moderate intensity active movement sequence consisting of repeated elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination.
The band is fully removed immediately following the 2-minute movement block
The floss band is applied to the participant's dominant upper arm by the same physiotherapist, maintaining identical therapist contact time, limb positioning, and overall session duration as the active group.
However, the band is applied with less than 10% elongation, creating a loosely snug contact fit insufficient to generate meaningful circumferential compression or local vascular occlusion.
Once wrapped, the participant performs the exact same 2-minute low-to-moderate intensity active movement sequence (elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination) before the band is fully removed.
|
|
Comparateur factice: Sham Flossing
Participants (n=14) receive a loose, minimal-tension wrap on their dominant upper arm using the same floss band type, performing the identical active movement sequence to isolate the effects of compression intensity
|
The floss band is applied to the participant's dominant upper arm by a licensed physiotherapist.
Wrapping proceeds in a distal-to-proximal direction with approximately 50% overlap between layers, terminating just distal to the axilla.
The band is stretched to a standardized elongation between 50% and 70% of its maximal length to generate moderate circumferential compression.
Once wrapped, the participant performs a standardized 2-minute low-to-moderate intensity active movement sequence consisting of repeated elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination.
The band is fully removed immediately following the 2-minute movement block
The floss band is applied to the participant's dominant upper arm by the same physiotherapist, maintaining identical therapist contact time, limb positioning, and overall session duration as the active group.
However, the band is applied with less than 10% elongation, creating a loosely snug contact fit insufficient to generate meaningful circumferential compression or local vascular occlusion.
Once wrapped, the participant performs the exact same 2-minute low-to-moderate intensity active movement sequence (elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination) before the band is fully removed.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Seated Medicine Ball Throw (SMBT) distance
Délai: Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal
|
Upper-extremity explosive power was assessed using the seated medicine ball throw.
Participants were seated upright with back support and projected a 2-kg medicine ball horizontally as far as possible in a chest-pass motion.
Throw distance was measured from a fixed start line to the point of initial ball contact.
|
Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal
|
|
Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) score
Délai: Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal.
|
Upper-extremity closed-chain stability was assessed using the CKCUEST.
Participants assumed a full push-up (high-plank) position with hands placed on two parallel strips of tape positioned 91.4 cm apart.
Participants alternately touched the opposite hand as rapidly as possible for 15 seconds.
The metric recorded is the total number of completed hand touches within the 15-second interval.
|
Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Esedullah AKARAS, Dr., Erzurum Technical University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- ETU-2026-TF-UEP-01
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .